Further studies to establish the phenotype associated with CFTR dysfunction among individuals with COPD are indicated, and together with the present findings, could form the basis for clinical intervention using CFTR potentiators in COPD. The gene discussed is CFTR; the disease is chronic obstructive pulmonary disease.